The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Activated T Cell Exosomes Promote Tumor Invasion via Fas Signaling Pathway
Abstract
Activated T cells release bioactive Fas ligand (FasL) in exosomes, which subsequently induce self-apoptosis of T cells. However, their potential effects on cell apoptosis in tumors are still unknown. In this study, we purified exosomes expressing FasL from activated CD8+ T cell from OT-I mice and found that activated T cell exosomes had little effect on apoptosis and proliferation of tumor cells but promoted the invasion of B16 and 3LL cancer cells in vitro via the Fas/FasL pathway. Activated T cell exosomes increased the amount of cellular FLICE inhibitory proteins and subsequently activated the ERK and NF-κB pathways, which subsequently increased MMP9 expression in the B16 murine melanoma cells. In a tumor-invasive model in vivo, we observed that the activated T cell exosomes promoted the migration of B16 tumor cells to lung. Interestingly, pretreatment with FasL mAb significantly reduced the migration of B16 tumor cells to lung. Furthermore, CD8 and FasL double-positive exosomes from tumor mice, but not normal mice, also increased the expression of MMP9 and promoted the invasive ability of B16 murine melanoma and 3LL lung cancer cells. In conclusion, our results indicate that activated T cell exosomes promote melanoma and lung cancer cell metastasis by increasing the expression of MMP9 via Fas signaling, revealing a new mechanism of tumor immune escape.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nagata, S. (1997) · Cell · doi:10.1016/s0092-8674(00)81874-7 · Cited by 4,938
Johnstone, R. M., Adam, M., Hammond, J. R., Orr, L., & Turbide, C. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)48095-7 · Cited by 2,931
The CD95(APO-1/Fas) DISC and beyond
Peter, M. E., & Krammer, P. H. (2003) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401186 · Cited by 1,080
Apoptosis signaling by death receptors
Schulze‐Osthoff, K., Ferrari, D., Los, M., Wesselborg, S., & Peter, M. E. (1998) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.1998.2540439.x · Cited by 978
NF-κB Signals Induce the Expression of c-FLIP
Micheau, O., Lens, S., Gaide, O., Alevizopoulos, K., & Tschopp, J. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.16.5299-5305.2001 · Cited by 813
FAP-1: A Protein Tyrosine Phosphatase That Associates with Fas
Sato, T., Irie, S., Kitada, S., & Reed, J. C. (1995) · Science · doi:10.1126/science.7536343 · Cited by 683
Activation‐induced cell death in T cells
Green, D. R., Droin, N., & Pinkoski, M. (2003) · Immunological Reviews · doi:10.1034/j.1600-065x.2003.00051.x · Cited by 647
c-FLIPL is a dual function regulator for caspase-8 activation and CD95-mediated apoptosis
Chang, D. W. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf356 · Cited by 563
Exosomes: immune properties and potential clinical implementations
Chaput, N., & Théry, C. (2011) · Seminars in Immunopathology · doi:10.1007/s00281-010-0233-9 · Cited by 560
The caspase-8 inhibitor FLIP promotes activation of NF-κB and Erk signaling pathways
Kataoka, T., Budd, R. C., Holler, N., Thome, M., Martinon, F., Irmler, M., Burns, K., Hahne, M., Kennedy, N., Kovacsovics, M., et al. (2000) · Current Biology · doi:10.1016/s0960-9822(00)00512-1 · Cited by 552
Boosting antitumor responses of T lymphocytes infiltrating human prostate cancers
Bronte, V., Kasic, T., Gri, G., Gallana, K., Borsellino, G., Marigo, I., Battistini, L., Iafrate, M., Prayer-Galetti, T., Pagano, F., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20042028 · Cited by 396
Chen, L., Park, S.-M., Tumanov, A. V., Hau, A., Sawada, K., Feig, C., Turner, J. R., Fu, Y.-X., Romero, I. L., Lengyel, E., et al. (2010) · Nature · doi:10.1038/nature09075 · Cited by 378
Activation of progelatinase B (MMP-9) by gelatinase A (MMP-2).
Fridman, R., Tóth, M., Peña, D., & Mobashery, S. (1995) · PubMed · Cited by 378
Yes and PI3K Bind CD95 to Signal Invasion of Glioblastoma
Kleber, S., Sancho-Martinez, I., Wiestler, B., Beisel, A., Gieffers, C., Hill, O., Thiemann, M., Mueller, W., Sykora, J., Kuhn, A., et al. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.02.003 · Cited by 309
Kim, Y., Suh, N., Sporn, M., & Reed, J. C. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202458200 · Cited by 309
Activated Human T Cells Release Bioactive Fas Ligand and APO2 Ligand in Microvesicles
Martínez-Lorenzo, M. J., Anel, A., Gamen, S., Monleón, I., Lasierra, P., Larrad, L., Piñeiro, A., Alava, M. A., & Naval, J. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.3.1274 · Cited by 307
CD95 ligand induces motility and invasiveness of apoptosis‐resistant tumor cells
Barnhart, B. C., Legembre, P., Pietras, E., Bubici, C., Franzoso, G., & Peter, M. E. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600325 · Cited by 284
c-FLIPR, a New Regulator of Death Receptor-induced Apoptosis
Golks, A., Brenner, D., Fritsch, C., Krammer, P. H., & Lavrik, I. N. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m414425200 · Cited by 282
Greer, G. (1968) · Cited by 279
REVIEW ARTICLE: The Role of Placental Exosomes in Reproduction
Mincheva‐Nilsson, L., & Baranov, V. (2010) · American Journal of Reproductive Immunology · doi:10.1111/j.1600-0897.2010.00822.x · Cited by 217
Chen, W., Wang, J., Shao, C., Liu, S., Yu, Y., Wang, Q., & Cao, X. (2006) · European Journal of Immunology · doi:10.1002/eji.200535501 · Cited by 209
Self-citationc-FLIP Mediates Resistance of Hodgkin/Reed-Sternberg Cells to Death Receptor–induced Apoptosis
Mathas, S., Lietz, A., Anagnostopoulos, I., Hummel, F., Wiesner, B., Janz, M., Jundt, F., Hirsch, B., Jöhrens-Leder, K., Vornlocher, H.-P., et al. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20031080 · Cited by 204
Dai, S., Wan, T., Wang, B., Zhou, X., Xiu, F., Chen, T., Wu, Y., & Cao, X. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0810 · Cited by 199
Self-citationThe Erk2 MAPK Regulates CD8 T Cell Proliferation and Survival
D'Souza, W. N., Chang, C.-F., Fischer, A. M., Li, M., & Hedrick, S. M. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.11.7617 · Cited by 193
Sharp, D. A., Lawrence, D. A., & Ashkenazi, A. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m413962200 · Cited by 156
The Molecular Interaction of Fas and FAP-1
Yanagisawa, J., Takahashi, M., Kanki, H., Yano-Yanagisawa, H., Tazunoki, T., Sawa, E., Nishitoba, T., Kamishohara, M., Kobayashi, E., Kataoka, S., et al. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.13.8539 · Cited by 138
Letellier, E., Kumar, S., Sancho-Martinez, I., Krauth, S. J., Funke-Kaiser, A., Laudenklos, S., Konecki, K., Klußmann, S., Corsini, N. S., Kleber, S., et al. (2010) · Immunity · doi:10.1016/j.immuni.2010.01.011 · Cited by 137
Xie, Y., Zhang, H., Li, W., Deng, Y., Munegowda, M. A., Chibbar, R., Qureshi, M., & Xiang, J. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000386 · Cited by 136
Fu, L., Zhang, C., Zhang, L.-Y., Dong, S.-S., Lu, L.-H., Chen, J., Dai, Y. D., Li, Y., Kong, K. L., Kwong, D. L. �., et al. (2011) · Gut · doi:10.1136/gut.2011.241638 · Cited by 134
Zhang, Y., Liu, Q., Zhang, M., Yu, Y., Liu, X., & Cao, X. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0801548 · Cited by 124
Self-citationShinohara, H., Yagita∥, H., Ikawa, Y., & Oyaizu, N. (2000) · PubMed · Cited by 111
A tumor-suppressor function for Fas (CD95) revealed in T cell-deficient mice.
Peng, S. L., Robert, M. E., Hayday, A., & Craft, J. E. (1996) · The Journal of Experimental Medicine · doi:10.1084/jem.184.3.1149 · Cited by 102
FLIP overexpression inhibits death receptor-induced apoptosis in malignant mesothelial cells
Rippo, M. R., Moretti, S., Vescovi, S., Tomasetti, M., Orecchia, S., AMICI, G., Catalano, A., & Procopio, A. D. (2004) · Oncogene · doi:10.1038/sj.onc.1208051 · Cited by 93
CD4−8− Dendritic Cells Prime CD4+ T Regulatory 1 Cells to Suppress Antitumor Immunity
Zhang, X., Huang, H., Yuan, J., Sun, D., Hou, W.-S., Gordon, J., & Xiang, J. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.5.2931 · Cited by 71
Rokhlin, O. W., Glover, R. A., & Cohen, M. B. (1998) · PubMed · Cited by 70
Subramanian, M., & Shaha, C. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.4.2330 · Cited by 70
Nijkamp, M. W., Hoogwater, F. J. H., Steller, E. J. A., Westendorp, B. F., van der Meulen, T. A., Leenders, M. W. H., Rinkes, I. H. M. B., & Kranenburg, O. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.04.040 · Cited by 63
van Deventer, H. W., Wu, Q., Bergstralh, D. T., Davis, B. K., O’Connor, B. P., Ting, J. P. ‐., & Serody, J. S. (2008) · American Journal Of Pathology · doi:10.2353/ajpath.2008.070732 · Cited by 63
Human and Mouse Colon Cancer Utilizes CD95 Signaling for Local Growth and Metastatic Spread to Liver
Li, H., Fan, X., Stoicov, C., Liu, J. H., Zubair, S., Tsai, E., Marie, R. S., Wang, T. C., Lyle, S. R., Kurt‐Jones, E. A., et al. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.06.004 · Cited by 57
Cellular immunotherapy for cancer
Armstrong, A. C., Eaton, D., & Ewing, J. C. (2001) · BMJ · doi:10.1136/bmj.323.7324.1289 · Cited by 56
Fas Signaling in Thyroid Carcinomas Is Diverted from Apoptosis to Proliferation
Mitsiades, C. S., Poulaki, V., Fanourakis, G., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-2493 · Cited by 55
PKC-mediated phosphorylation regulates c-FLIP ubiquitylation and stability
Kaunisto, A., Kochin, V., Asaoka, T., Mikhailov, A., Poukkula, M., Meinander, A., & Eriksson, J. (2009) · Cell Death and Differentiation · doi:10.1038/cdd.2009.35 · Cited by 54
II. Intestinal epithelial cell exosomes: perspectives on their structure and function
van Niel, G., & Heyman, M. (2002) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00102.2002 · Cited by 45
Li, Y., Raffo, A. J., Drew, L., Mao, Y., Tran, A., Petrylak, D. P., & Fine, R. L. (2003) · PubMed · Cited by 43
Kim, H., Song, J., Cho, J. Y., Yoon, Y.-S., Han, H., Lee, H. S., Ryu, H. S., & Choe, G. (2010) · Journal of Clinical Pathology · doi:10.1136/jcp.2010.080713 · Cited by 25
Toivonen, H. T. T., Meinander, A., Asaoka, T., Westerlund, M., Pettersson, F., Mikhailov, A., Eriksson, J., & Saxén, H. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.177097 · Cited by 17
Cited by
Biological properties of extracellular vesicles and their physiological functions
Yáñez‐Mó, M., Siljander, P. R. ‐., Andreu, Z., Bedina Zavec, A., Borràs, F. E., Buzas, E. I., Buzas, K., Casal, E., Cappello, F., Carvalho, J., et al. (2015) · Journal of Extracellular Vesicles · doi:10.3402/jev.v4.27066 · Cited by 5,926
Extracellular vesicles: biology and emerging therapeutic opportunities
EL Andaloussi, S., Mäger, I., Breakefield, X. O., & Wood, M. J. A. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd3978 · Cited by 3,571
In Vivo Imaging Reveals Extracellular Vesicle-Mediated Phenocopying of Metastatic Behavior
Zomer, A., Maynard, C., Verweij, F. J., Kamermans, A., Schäfer, R., Beerling, E., Schiffelers, R. M., de Wit, E., Berenguer, J., Ellenbroek, S. I. J., et al. (2015) · Cell · doi:10.1016/j.cell.2015.04.042 · Cited by 869
Exosomes in cancer: small particle, big player
Zhang, X., Yuan, X., Shi, H., Wu, L., Qian, H., & Xu, W. (2015) · Journal of Hematology & Oncology · doi:10.1186/s13045-015-0181-x · Cited by 780
Exosomes and other extracellular vesicles in host–pathogen interactions
Schorey, J. S., Cheng, Y., Singh, P. P., & Smith, V. L. (2015) · EMBO reports · doi:10.15252/embr.201439363 · Cited by 727
Metadata
- Authors
- Cai, Z., Yang, F., Yu, L., Yu, Z., Jiang, L., Wang, Q., Yang, Y., Wang, L., Cao, X., & Wang, J.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2012-06
- Volume
- 188
- Issue
- 12
- Pages
- 5954-5961
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W2110964883
- Cited by
- 265
- References
- 46
- FWCI
- 5.00
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.